The annual risk of tuberculosis infection in newly hired researchers and healthcare workers using interferon-gamma release assay in Japan. Issue 8 (August 2020)
- Record Type:
- Journal Article
- Title:
- The annual risk of tuberculosis infection in newly hired researchers and healthcare workers using interferon-gamma release assay in Japan. Issue 8 (August 2020)
- Main Title:
- The annual risk of tuberculosis infection in newly hired researchers and healthcare workers using interferon-gamma release assay in Japan
- Authors:
- Nishimura, Tomoyasu
Ota, Masaki
Mori, Masaaki
Takano, Yaoko
Fujiwara, Hiroshi
Uwamino, Yoshifumi
Uno, Shunsuke
Hasegawa, Naoki - Abstract:
- Abstract: The tuberculosis (TB) notification rate in Japan is gradually decreasing but has not yet achieved "pre-elimination, " defined by the World Health Organization. To effectively tackle, control, and eliminate TB, estimating and monitoring the annual risk of TB infection (ARI) using tuberculin skin testing (TST) to understand the dynamics of TB epidemiology are significantly important. However, studies estimating ARIs using TST are few considering that Bacillus Calmette-Guérin vaccination coverage is high in Japan. This was a single-center, cross-sectional study conducted between January 2011 and December 2018 in Tokyo area where interferon-gamma release assays (IGRAs) were performed in newly hired researchers of Keio University School of Medicine and healthcare workers of Keio University Hospital to determine TB infection. We estimated the prevalence of TB infection and ARI based on their IGRA results. Among the 3908 subjects, 83 (2.124%) had positive IGRA results. Multiple logistic regression analysis revealed that age was a significant risk factor for positive IGRA result (adjusted odds ratio, 1.046). The ARIs were 0.049%–0.156% between 1986 and 2004, midyears of TB infection, but have not significantly decreased over approximately two decades. To decrease the risk of TB infection, advanced strategies to control and eliminate TB in Tokyo area are significantly required.
- Is Part Of:
- Journal of infection and chemotherapy. Volume 26:Issue 8(2020:Aug.)
- Journal:
- Journal of infection and chemotherapy
- Issue:
- Volume 26:Issue 8(2020:Aug.)
- Issue Display:
- Volume 26, Issue 8 (2020)
- Year:
- 2020
- Volume:
- 26
- Issue:
- 8
- Issue Sort Value:
- 2020-0026-0008-0000
- Page Start:
- 818
- Page End:
- 822
- Publication Date:
- 2020-08
- Subjects:
- Mycobacterium tuberculosis -- Interferon-gamma release assay -- Annual risk of tuberculosis infection
Chemotherapy -- Periodicals
Infection -- Periodicals
Communicable diseases -- Chemotherapy -- Periodicals
615.5805 - Journal URLs:
- http://www.sciencedirect.com/science/journal/1341321X ↗
http://link.springer-ny.com/link/service/journals/10156/index.htm ↗
http://www.springerlink.com/content/1341-321x ↗
http://www.elsevier.com/journals ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1016/j.jiac.2020.03.020 ↗
- Languages:
- English
- ISSNs:
- 1341-321X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5006.691000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13430.xml